Vascular Endothelial Growth Factor Pathway

被引：3

作者：

Krupitskaya, Yelena ^{[1
]}

Wakelee, Heather ^{[1
]}

机构：

[1] Stanford Univ, Dept Med, Div Oncol, Stanford Canc Ctr, Stanford, CA 94305 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 11期

关键词：

CELL LUNG-CANCER; ANGIOGENESIS; BEVACIZUMAB; CARBOPLATIN;

D O I：

10.1097/01.JTO.0000361755.32660.a1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S1071 / S1073

页数：3

共 10 条

[1] Acceptable safety of bevacizumab therapy in patients with brain metastases due to non-small cell lung cancer [J].

Akerley, W. L. ;

Langer, C. J. ;

Oh, Y. ;

Strickland, D. K. ;

Royer, S. Joo ;

Xia, Q. ;

Mu, Y. ;

Huang, J. ;

Socinski, M. A. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[2] Cellular abnormalities of blood vessels as targets in cancer [J].

Baluk, P ;

Hashizume, H ;

McDonald, DM .

CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (01) :102-111

[3] WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].

FOLKMAN, J .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6

[4] Lymphatic endothelial regulation, lymphoedema, and lymph node metastadsis [J].

Karkkainen, MJ ;

Alitalo, K .

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2002, 13 (01) :9-18

[5] Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer: AVAiL [J].

Reck, Martin ;

von Pawel, Joachim ;

Zatloukal, Petr ;

Ramlau, Rodryg ;

Gorbounova, Vera ;

Hirsh, Vera ;

Leighl, Natasha ;

Mezger, Joerg ;

Archer, Venice ;

Moore, Nicola ;

Manegold, Christian .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) :1227-1234

[6] VEGF receptor protein-tyrosine kinases: Structure and regulation [J].

Roskoski, Robert, Jr. .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 375 (03) :287-291

[7] Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer [J].

Sandler, Alan ;

Gray, Robert ;

Perry, Michael C. ;

Brahmer, Julie ;

Schiller, Joan H. ;

Dowlati, Afshin ;

Lilenbaum, Rogerio ;

Johnson, David H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (24) :2542-2550

[8] Retrospective Evaluation of the Clinical and Radiographic Risk Factors Associated With Severe Pulmonary Hemorrhage in First-Line Advanced, Unresectable Non-Small-Cell Lung Cancer Treated With Carboplatin and Paclitaxel Plus Bevacizumab [J].

Sandler, Alan B. ;

Schiller, Joan H. ;

Gray, Robert ;

Dimery, Isaiah ;

Brahmer, Julie ;

Samant, Meghna ;

Wang, Lisa I. ;

Johnson, David H. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) :1405-1412

[9]

Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469

[10] Targeting Angiogenesis in the Treatment of Lung Cancer [J].

Wheatley-Price, Paul ;

Shepherd, Frances A. .

JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (10) :1173-1184

← 1 →